大比泻兰乙二醇酯杂质64 | 355809-32-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 大比泻兰乙二醇酯杂质64
• 英文名称: 2-[(4-carbamoylphenyl)amino]acetic Acid
• 英文别名: 2-(4-carbamoylanilino)acetic acid
• CAS: 355809-32-4
• 化学式: C₉H₁₀N₂O₃
• mdl: MFCD00461104
• 分子量: 194.19
• InChiKey: VYFGVOMFCZSJPI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.5
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.111
• 拓扑面积：
  92.4
• 氢给体数：
  3
• 氢受体数：
  4

文献信息

• CYCLIC N,N'-DIARYLTHIOUREAS AND N,N'-DIARYLUREAS - ANDROGEN RECEPTOR ANTAGONISTS, ANTICANCER AGENT, METHOD FOR PREPARATION AND USE THEREOF
  申请人：Ivachtchenko Alexandre Vasilievich

  公开号：US20130116269A1

  公开（公告）日：2013-05-09

  The present invention relates to novel cyclic N,N′-diarylureas and N,N′-diarylthioureas—androgen receptor antagonists, anti-cancer agent, pharmaceutical composition, medicament, and method for treatment of cancerous diseases, among them prostate cancer. Cyclic N,N′-diarylthioureas or N,N′-diarylureas of the general formula 1, their optical (R)- and (S)-isomers and pharmaceutically acceptable salts thereof exhibiting properties of androgen receptor antagonists have been proposed, wherein: X represents oxygen or sulfur; m=0 or 1; R1 represents C 1 -C 3 alkyl; R2 and R3 represent hydrogen; or R2 and R3 together with C-atom they are attached to form C═O group; R4 and R5 represent hydrogen; or R4 represents hydrogen, R5 represents methyl; or R4 represents methyl, R5 represents CH 2 R6 group in which R6 represents C 1 -C 3 alkoxycarbonyl, carboxyl, hydroxyl group optionally substituted with methyl or benzyl; or R4 and R5 together with C-atom they are attached to form 5- or 6-membered heterocycle comprising at least one oxygen atom or nitrogen atom optionally substituted with methyl; or R4 and R5 together with C-atom they are attached to form NH group.

  本发明涉及新颖的环状N,N′-二芳基脲和N,N′-二芳基硫脲—雄激素受体拮抗剂、抗癌剂、药物组合物、药物以及治疗癌症性疾病的方法，其中包括前列腺癌。已经提出了一般式1的环状N,N′-二芳基硫脲或N,N′-二芳基脲，它们的光学异构体(R)-和(S)-以及其药用盐具有雄激素受体拮抗剂的性质，其中：X代表氧或硫；m=0或1；R1代表C1-C3烷基；R2和R3代表氢；或R2和R3与它们连接的C原子一起形成C═O基团；R4和R5代表氢；或R4代表氢，R5代表甲基；或R4代表甲基，R5代表CH2R6基团，其中R6代表C1-C3烷氧羰基、羧基、羟基，可选择地被甲基或苄基取代；或R4和R5与C原子一起形成至少含有一个氧原子或氮原子的5-或6元杂环；或R4和R5与C原子一起形成NH基团。
• CYCLIC N,N'-DIARYLTHIOUREA - ANDROGEN RECEPTOR ANTAGONIST, ANTI BREAST CANCER COMPOSITION AND USE THEREOF
  申请人：IVACHTCHENKO Alexandre Vasilievich

  公开号：US20130252992A1

  公开（公告）日：2013-09-26

  The present invention relates to novel cyclic N,N′-diarylurea-androgen receptor antagonist, anti-cancer agent, pharmaceutical composition, medicament, and method for treatment of breast cancer disease. Cyclic N,N′-diarylthioureas or N,N′-diarylureas of the general formula 1, their optical (R)- and (S)-isomers and pharmaceutically acceptable salts thereof exhibiting properties of androgen receptor antagonists have been proposed, wherein: R1 represents C 1 -C 3 alkyl; R4 and R5 represent hydrogen; or R4 represents hydrogen, R5 represents methyl; or R4 represents methyl, R5 represents CH 2 R6 group in which R6 is C 1 -C 3 alkoxycarbonyl, carboxyl, hydroxyl group optionally substituted with methyl or benzyl; or R4 and R5 together with the carbon atom they are attached to form 5- or 6-membered saturated heterocycle including at least one oxygen atom or nitrogen atom optionally substituted with methyl.

  本发明涉及一种新型的环状N,N′-二芳基脲-雄激素受体拮抗剂、抗癌剂、制药组合物、药物以及治疗乳腺癌疾病的方法。已经提出了一种具有雄激素受体拮抗剂性质的通式1的环状N,N′-二芳基硫脲或N,N′-二芳基脲，它们的光学异构体(R)-和(S)-异构体以及其药学上可接受的盐，其中：R1代表C1-C3烷基；R4和R5代表氢；或R4代表氢，R5代表甲基；或R4代表甲基，R5代表CH2R6基团，其中R6是C1-C3烷氧基羰基、羧基、羟基，可选地取代甲基或苄基；或R4和R5与它们所连接的碳原子一起形成5-或6-成员饱和杂环，包括至少一个氧原子或氮原子，可选地取代甲基。
• Image forming layer
  申请人：Fuji Photo Film Co., Ltd.

  公开号：EP0458485A2

  公开（公告）日：1991-11-27

  An image forming layer comprising a polymer which has a component showing UV absorption at 320 nm or higher and a component containing the carboxylic acid (carboxylate) group represented by the following general formula I:         -(Y)₁ -X-(CH₂)k -COOT   (I) wherein X represents sulfur, oxygen, single bond, C=W or N-U where W represents oxygen or sulfur and U represents an optionally substituted aryl, alkyl group or hydrogen, Y represents an optionally substituted alkylene, arylene, aralkylene group or divalent heterocyclic ring, and T represents a hydrogen, alkali metal, alkaline earth metal or HN(R¹)(R²)(R³) where R¹, R² and R³, which may be identical or different, independently represent a hydrogen atom, optionally substituted alkyl or aryl group and R¹, R² and R³ may join together to form a ring structure, k represents 0 or 1 and l is 0 or 1, provided that X represents C=W when k is 0. The image forming layer shows an extremely high sensitivity and excellent cratch resistance of the image areas upon development.

  一种图像形成层，由一种聚合物和一种含有羧酸（羧酸盐）基团的组分组成，前者具有 320 纳米或更高的紫外线吸收率，后者由以下通式 I 表示： -(Y)₁ -X-(CH₂)k -COOT (I) 其中 X 代表硫、氧、单键、C=W 或 N-U，其中 W 代表氧或硫，U 代表任选取代的芳基、烷基或氢，Y 代表任选取代的亚烷基、亚芳基、芳烷基或二价杂环，T 代表氢、碱金属、碱土金属或 HN(CH₂)k、其中 R¹、R² 和 R³ 可以相同或不同，各自代表氢原子、任选取代的烷基或芳基，R¹、R² 和 R³ 可以连接在一起形成环状结构，k 代表 0 或 1，l 代表 0 或 1，条件是当 k 为 0 时，X 代表 C=W。图像形成层在显影时显示出极高的灵敏度和图像区域极佳的抗擦伤性。
• CYCLIC N,N'-DIARYLTHIOUREAS AND N,N'-DIARYLUREAS AS ANDROGEN RECEPTOR ANTAGONISTS, ANTI-CANCER AGENT, METHOD FOR PRODUCING AND USING SAME
  申请人：Ivachtchenko, Alexandre Vasilievich

  公开号：EP2597086A1

  公开（公告）日：2013-05-29

  The present invention relates to novel cyclic N,N'-diarylureas and N,N'-diarylthioureas - androgen receptor antagonists, anti-cancer agent, pharmaceutical composition, medicament, and method for treatment of cancerous diseases, among them prostate cancer. Cyclic N,N'-diarylthioureas or N,N'-diarylureas of the general formula 1, their optical (R)- and (S)- isomers and pharmaceutically acceptable salts thereof exhibiting properties of androgen receptor antagonists have been proposed, wherein: X represents oxygen or sulfur; m = 0 or 1; R1 represents C1-C3alkyl; R2 and R3 represent hydrogen; or R2 and R3 together with C-atom they are attached to form C = O group; R4 and R5 represent hydrogen; or R4 represents hydrogen, R5 represents methyl; or R4 represents methyl, R5 represents CH2R6 group in which R6 represents C1-C3 alkoxycarbonyl, carboxyl, hydroxyl group optionally substituted with methyl or benzyl; or R4 and R5 together with C-atom they are attached to form 5- or 6- membered heterocycle comprising at least one oxygen atom or nitrogen atom optionally substitutd with methyl; or R4 and R5 together with C-atom they are attached to form NH group.

  本发明涉及新型环状N,N'-二芳基脲类和N,N'-二芳基硫脲类--雄激素受体拮抗剂、抗癌剂、药物组合物、药物和治疗癌症疾病（其中包括前列腺癌）的方法。 已经提出了通式 1 的环状 N,N'-二芳基硫脲或 N,N'-二芳基硫脲、它们的光学 (R)- 和 (S)- 异构体及其药学上可接受的盐，它们具有雄激素受体拮抗剂的特性、 其中X 代表氧或硫； m = 0 或 1； R1 代表 C1-C3 烷基； R2和R3代表氢；或 R2 和 R3 与它们连接的 C 原子一起形成 C = O 基团； R4 和 R5 代表氢；或 R4 代表氢，R5 代表甲基；或 R4 代表甲基，R5 代表 CH2R6 基团，其中 R6 代表任选被甲基或苄基取代的 C1-C3 烷氧基羰基、羧基、羟基；或 R4 和 R5 与它们所连接的 C 原子一起形成 5 或 6 位杂环，该杂环包含至少一个任选被甲基取代的氧原子或氮原子；或 R4 和 R5 与它们连接的 C 原子形成 NH 基团。
• Cyclic n,n'-diarylthioureas and n,n'-diarylureas as androgen receptor antagonists, anti-cancer agent, method for producing and using same
  申请人：Ivachtchenko, Alexandre Vasilievich

  公开号：EP2767531B1

  公开（公告）日：2016-12-21